IP Verse

Process For Preparing Carrier Particles For Dry Powders For Inhalation - EP2552424

The patent EP2552424 was granted to Chiesi Farmaceutici on May 9, 2018. The application was originally filed on Mar 11, 2011 under application number EP11712196A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2552424

CHIESI FARMACEUTICI
Application Number
EP11712196A
Filing Date
Mar 11, 2011
Status
Opposition Rejected
Nov 10, 2023
Grant Date
May 9, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

POLPHARMAFeb 7, 2019HOFFMANN EITLEADMISSIBLE
ZBM PATENTS ZEAJan 8, 2019ZBM PATENTS ZEAADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS4008209
DESCRIPTIONUS4086219
DESCRIPTIONUS4124577
DESCRIPTIONUS4317815
DESCRIPTIONUS5110904
DESCRIPTIONUS6528096
DESCRIPTIONWO0053158
DESCRIPTIONWO2004012801
DESCRIPTIONWO2004073827
DESCRIPTIONWO2008114052
DESCRIPTIONWO2008155570
DESCRIPTIONWO2010007447
INTERNATIONAL-SEARCH-REPORTEP2080508
INTERNATIONAL-SEARCH-REPORTWO0053157
INTERNATIONAL-SEARCH-REPORTWO2009001064
OPPOSITIONEP2621494
OPPOSITIONUS6645466
OPPOSITIONWO0053157
OPPOSITIONWO0178694
OPPOSITIONWO2005105043
OPPOSITIONWO2009001064
OPPOSITIONWO2009061273
OPPOSITIONWO2012041717

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- COLOMBO et al., "Comparative Evaluation of Structure and Micromeritics Properties of Magnesium Stearate", II Farmaco, (19840000), vol. 39, no. 10, pages 328 - 341, XP055562006-
OPPOSITION- KUMON et al., "Application and Mechanism of Inhalation Profile Improvement of DPI Formulations by Mechanofusion with Magnesium Stearate", Chem. Pharm. Bull., (20080000), vol. 56, no. 5, pages 617 - 625, XP002603347-
OPPOSITION- Y. OUABBAS et al., "Particle -particle coating in a Cyclomix impact mixer", Powder Technology, (20090000), vol. 189, pages 245 - 252, XP025884754
OPPOSITION- CARLI et al., "Influence of Porosity on the Contact Angle of Non-wettable Solids", J. Pharm. Pharmacol., (19830000), vol. 35, pages 404 - 405, XP055562035
OPPOSITION- KUMON et al., "Novel Approach to DPI Carrier Lactose with Mechanofusion Process with Additives and Evaluation by IGC", Chem. Pharm. Bull., (20060000), vol. 54, no. 11, pages 1508 - 1514, XP055561992
OPPOSITION- GERA et al., "Mechanical Methods for Dry Particle Coating Processes and Their Applications in Drug Delivery and Development", Recent Patents on Drug Delivery & Formulation, (20100000), vol. 4, pages 58 - 81, XP055059149
OPPOSITION- J. BOSSERT et al., "Effect of mixing on the lubrication of crystalline lactose by magnesium stearate", Drug Development and Industrial Pharmacy, (19800000), pages 573 - 589, XP055561917

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents